Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030
The REDCap consortium: Building an international community of software platform partners
Non-alcoholic fatty liver disease – A global public health perspective
Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease
Review article: the epidemiologic burden of non‐alcoholic fatty liver disease across the world
Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States
Roles of alcohol consumption in fatty liver: A longitudinal study
Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020
Prevalence of fatty liver and advanced fibrosis by ultrasonography and FibroScan in a general population random sample
Trends and Disparities in Adult Body Mass Index Across the 47 Prefectures of Japan, 1975–2018: A Bayesian Spatiotemporal Analysis of National Household Surveys
Economic costs of overweight and obesity
Reconsidering low HDL-cholesterol levels as a predictive factor for the development of hepatocellular carcinoma
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
Clinical Outcomes in Biopsy-Proven Nonalcoholic Fatty Liver Disease Patients: A Multicenter Registry-based Cohort Study
Impact of non-invasive biomarkers on hepatology practice: Past, present and future
Health Effects of Overweight and Obesity in 195 Countries over 25 Years
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
Noninvasive assessment of liver fibrosis and its clinical significance in nonalcoholic fatty liver disease
Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD
Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: A meta‐analysis
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research Gaps
Cohort Study of Non-alcoholic Fatty Liver Disease, NAFLD fibrosis score, and the Risk of Incident Diabetes in a Korean population
Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease
Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
The NAFLD fibrosis score
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes
Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support
Limitations of non-invasive tests for assessment of liver fibrosis
Medical care expenditure associated with body mass index in Japan: the Ohsaki Study
Diagnostic criteria for dyslipidemia — executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese